Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ananthakrishnan

Showing results (491-500 of 592) with videos related to

Pageof 60
Sort By:
Digestive Diseases and Sciences|November 20, 2016
Erratum to: Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel DiseasesBetsy W Stevens, Nynke Z Borren, Gabriella Velonias, et al.
Inflammatory Bowel Diseases|May 23, 2018
IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's DiseaseTracey G Simon, Kimberley W J Van Der Sloot, Samantha B Chin, et al.
BMJ (Clinical Research Ed.)|November 16, 2013
Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohortsHamed Khalili, Ashwin N Ananthakrishnan, Gauree G Konijeti, et al.
Gastroenterology|August 26, 2018
Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health StudyKristin E Burke, Ashwin N Ananthakrishnan, Paul Lochhead, et al.
Gastroenterology|February 23, 2023
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative ColitisSiddharth Singh, Ashwin N Ananthakrishnan, Nghia H Nguyen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2026
Collagen-binding probe PET/MR for distinguishing fibrotic from inflammatory strictures in Crohn's diseaseAntonino Andrea Blandino, Peter Caravan, Rocco Ricciardi, et al.
JAMA Network Open|February 6, 2026
Comparative Safety of Advanced Therapies for Crohn DiseaseSoo-Kyung Park, Dhruv Ahuja, Kuan-Hung Yeh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2019
Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative ColitisChristopher Ma, William J Sandborn, Geert R D'Haens, et al.
Inflammatory Bowel Diseases|August 6, 2008
Budesonide induction and maintenance therapy for Crohn's disease during pregnancyDawn B Beaulieu, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Inflammatory Bowel Diseases|November 20, 2009
Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's diseaseDaniel J Stein, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Pageof 60

Showing results (491-500 of 592) with videos related to

Sort By:
Pageof 60
Digestive Diseases and Sciences|November 20, 2016
Erratum to: Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel DiseasesBetsy W Stevens, Nynke Z Borren, Gabriella Velonias, et al.
Inflammatory Bowel Diseases|May 23, 2018
IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's DiseaseTracey G Simon, Kimberley W J Van Der Sloot, Samantha B Chin, et al.
BMJ (Clinical Research Ed.)|November 16, 2013
Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohortsHamed Khalili, Ashwin N Ananthakrishnan, Gauree G Konijeti, et al.
Gastroenterology|August 26, 2018
Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health StudyKristin E Burke, Ashwin N Ananthakrishnan, Paul Lochhead, et al.
Gastroenterology|February 23, 2023
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative ColitisSiddharth Singh, Ashwin N Ananthakrishnan, Nghia H Nguyen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 16, 2026
Collagen-binding probe PET/MR for distinguishing fibrotic from inflammatory strictures in Crohn's diseaseAntonino Andrea Blandino, Peter Caravan, Rocco Ricciardi, et al.
JAMA Network Open|February 6, 2026
Comparative Safety of Advanced Therapies for Crohn DiseaseSoo-Kyung Park, Dhruv Ahuja, Kuan-Hung Yeh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2019
Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative ColitisChristopher Ma, William J Sandborn, Geert R D'Haens, et al.
Inflammatory Bowel Diseases|August 6, 2008
Budesonide induction and maintenance therapy for Crohn's disease during pregnancyDawn B Beaulieu, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Inflammatory Bowel Diseases|November 20, 2009
Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's diseaseDaniel J Stein, Ashwin N Ananthakrishnan, Mazen Issa, et al.
Pageof 60